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a3 knock out mouseOsteoclasts acidify bone resorption lacunae through proton translocation by plasma membrane V-ATPase
(vacuolar-type ATPase) which has an a3 isoform, one of the four isoforms of the trans-membrane a subunit
(Toyomura et al., J. Biol. Chem., 278, 22023–22030, 2003). d2, a kidney- and epididymis-speciﬁc isoform of the d
subunit, was also induced in osteoclast-like cells derived from the RAW264.7 line, and formed V-ATPasewith a3.
The amount of d2 in osteoclasts was 4-fold higher than that of d1, a ubiquitous isoform. These results indicate
that V-ATPase with d2/a3 is a major osteoclast proton pump. Essentially the same results were obtained with
osteoclasts derived from mouse spleen macrophages.
Macrophages from a3-knock-out mice could differentiate into multi-nuclear cells with osteoclast-speciﬁc
enzymes. In these cells, the d2 isoform was also induced and assembled in V-ATPase with the a1 or a2 isoform.
However, they did not absorb calcium phosphate, indicating that V-ATPase with d2/a1 or d2/a2 could not
perform the function of that with d2/a3.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Bone homeostasis is maintained through the equilibrium between
resorption by osteoclasts and bonegenesis by osteoblasts. Reduced and
increased bone resorptions cause osteopetrosis and osteoporosis,
respectively [1,2]. Osteoclasts tightly attached to the bone surface
secrete protons and lysosomal enzymes into bone resorption lacuna, a
compartment between osteoclasts and bone [3]. Proton pumping
vacuolar-type ATPase (V-ATPase) in the osteoclast plasma membrane
is responsible for this acidiﬁcation [4,5]. Murine macrophage line
RAW264.7 can form osteoclast-like multinuclear cells upon incubation
with the extracellular domain of RANKL (receptor activator of nuclear
factor κB ligand) [6]. The differentiated cells express osteoclast-speciﬁc
enzymes in addition to V-ATPase.
V-ATPase is a multi-subunit enzyme formed from peripheral V1 and
membrane V0 sectors, which function as a catalytic sector and a proton
channel, respectively [7,8]. Consistent with its diverse physiological
roles, V-ATPase has a number of subunit isoforms of V0 (a and d) andL, receptor activator of nuclear
lating factor; GST, glutathione
iamine-N,N,N′,N′-tetraacetic
phosphatase
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ishi-Matsui).V1 (B, C, E, and G) [8–10]. One of the four isoforms (a1, a2, a3, and a4)
of the a subunit, a3, is a component of lysosomal andosteoclast enzymes
[6,11]. Detailed studies on RAW264.7-derived osteoclasts suggested
that lysosomeshavingV-ATPasewith a3 are targeted to the cell periphery
and then become localized in the plasma membrane [6]. Consistently,
disruption of the gene for a3 causes osteopetrosis with impaired bone
resorption [12–14].
Similar to a3, d2 is induced during osteoclast differentiation [15–17].
Analysis of osteoclasts from d2 gene-deﬁcient mice or from knock-
down cells revealed that d2 plays important roles in cell fusion during
differentiation into osteoclasts and in acidiﬁcation of bone resorption la-
cunae [16,17]. However, association of a3 and d2 in the same V-ATPase
has not been shown in osteoclasts, although d2 is immuno-precipitated
with a3 when the tagged proteins are expressed in HEK-293T cells
derived from the human embryonic kidney [17]. It is also of interest to
determine whether or not a3 and d2 are expressed similarly during
differentiation.
In this study, we found in mature osteoclasts that d2 is expressed at
a 4-fold higher level than d1, a ubiquitous isoform, and assembled in
V-ATPase togetherwith a3. Spleenmacrophages from a3 gene-deﬁcient
mice could differentiate into osteoclasts, however, they did not absorb
calcium phosphate. Interestingly, the d2 isoform was induced similar
in wild-type macrophages, and formed a V-ATPase with a1 or a2 in
these cells. These results suggest that V-ATPase with a3/d2, not a1/d2
and a2/d2, plays a pivotal role in bone resorption.
Fig. 1. Protein expression during differentiation into osteoclasts from RAW264.7 cells. (A) Time courses of protein expression during osteoclast differentiation. RAW264.7 cells were
cultured for 0, 1, 2, 3, or 4 days with RANKL. After total cell protein (20 μg) had been separated by gel electrophoresis, a3, d1, d2, CathK, TRAP, and α-tubulin were detected with the
corresponding antibodies. (B) Titration for estimating the amount of the d1 isoform. The recombinant d1 protein, 0.1–1 ng, was detected on Western blotting with antibodies against
d1 (upper panel), and the intensity of each signal was quantiﬁed with an LAS-3000. A typical titration for determining the amount of d1 is shown (lower panel). Standard error bars are
smaller than the symbols. Similar titration was carried out for the d2 isoform (not shown). (C) Amounts of the d1 and d2 isoforms in progenitors and osteoclasts. After total protein
had been obtained from the cells treated with (+) or without (−) RANKL, the amounts of d1 (open bars) and d2 (gray bar) isoforms were estimated by titration as shown in (B). The
amount of d1 or d2 in 10 μg total cell protein is shown. (D) Presence of d1, d2, and a3 isoforms in the organelle fraction. Cell lysates were prepared from RAW264.7 cells treated with
(+) or without (−) RANKL. Post-nuclear supernatants (PNS), the organelle (Org.) and cytosol (Cyt.) fractions were subjected toWestern blotting. Theα-tubulinwas used as a control cy-
tosolic protein.
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2.1. Cell culture and expression of FLAG-tagged d isoforms
RAW264.7 cells obtained from the European Collection of Cell Cul-
ture (ECACC Cat. 91062702) were grown in Dulbecco's Modiﬁed Eagle
Medium as described previously [18]. A stable RAW264.7 line express-
ing FLAG-tagged d1 or d2 was isolated after retrovirus infection using
a Platinum Retrovirus Expression System (Cell Biolabs, San Diego,
USA) and selectionwith 5 μg/mL puromycin. All reagents for cell culture
were fromLife Technologies (NY, USA). The a3-deﬁcientmicewere gen-
erated by crossing C57BL/6-a3+/−mice (BRC No. 04421) obtained from
the RIKEN BioResource Center (Tsukuba, Japan) [19]. Macrophages
were isolated from spleen cells of C57BL/6 or C57BL/6-a3−/− mice
(2 weeks old), and cultured in MEMα containing 10% fetal bovine
serum, antibiotics, and 25 ng/mL M-CSF (macrophage-colony stimulat-
ing factor) (R&D Systems, Minneapolis, USA). For osteoclast differentia-
tion, RAW264.7 cells and spleen macrophages were cultured in the
presence of 100 and 200 ng/mL RANKL (Peprotech, Rocky Hill, NJ),
respectively. Actin and nuclei were stained with phalloidin and
Hoechst33342, respectively [18]. The pit formation assay was per-
formed using calcium phosphate coated dish (Corning, NY, USA).2.2. Puriﬁcation of the d1 and d2 isoforms
The cDNAs encoding d1 and d2 were synthesized by RT-PCR using
mRNA from RAW264.7-derived osteoclasts and speciﬁc primers, sense
strand sequence for d1 (5′-GACAGGATCCTCGTTCTTCCCGGAGCTC-3′),
anti-sense strand sequence for d1 (5′-AATTGCGGCCGCCTAAAAGATG
GGGATGTA-3′), sense strand sequence for d2 (5′-ATGCGGATCCCTTG
AGACTGCAGAGCTG-3′), and anti-sense strand sequence for d2 (5′-
GTACGCGGCCGCTTATAAAATTGGAATGTA-3′), and cloned into the
pGEX-6p vector (GE Healthcare, Buckinghamshire, UK). The GST (gluta-
thione S-transferase)-fused d1 and d2 isoforms were expressed in
Escherichia coli and puriﬁed with glutathione-Sepharose. After removal
of the GST tag, d1 and d2were used as standards for estimation of their
amounts in osteoclasts.2.3. Immuno-precipitation and Western blot analysis
Cells cultured with or without RANKL were lysed with IP buffer
(1% Triton X-100, 10% glycerol, 50 mM Tris–HCl (pH7.4), 150 mM
NaCl, 1 mM DTT, 1 mM EDTA, protease inhibitors). The lysates
were subjected to immuno-precipitation as described previously
Fig. 2. V-ATPase with d2 and a3 isoforms in osteoclasts derived from RAW264.7 cells.
RAW264.7 cells were treated with (+) or without (−) RANKL for 4 days. Cell lysates
were subjected to immuno-precipitation using pre-immune serum (lanes 1 and 4), and
antibodies against a3 (lanes 2 and 3) and B2 (lanes 5 and 6). The precipitates were
analyzed by blotting using antibodies against the indicated proteins.
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blot analysis [18]. Immunodetection was carried out using horseradish
peroxidase-conjugated antibodies and an ECL luminescence detection
system (GE Healthcare). Antibodies against a3, d2, cathepsin K, and α-
tubulin were obtained as described previously [18]. Antibodies against
β-actin and B2were purchased from Sigma-Aldrich (MO, USA). An anti-
body against TRAP (tartrate-resistant acid phosphatase) was from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). A chicken monoclonal anti-
body against a2was generated as described previously [21]. Antibodies
against the mouse a1 and d1 isoforms were prepared using synthetic
peptides corresponding to Gly680–His693 of a1 (Life Technologies)
and to Val69–Tyr90 of mouse d1 (Greiner Bio-one, Tokyo, Japan), re-
spectively. Signals observed on Western blotting were quantiﬁed using
an LAS-3000.
2.4. Subcellular fractionation
RAW264.7 and RAW264.7-derived osteoclasts were disrupted in
0.25 M sucrose containing 3 mM imidazole (pH–7.4), 0.5 mM EDTA,
and protease inhibitors, and centrifuged at 750 ×g for 5 min. The
resulting post-nuclear supernatant was centrifuged at 100,000 ×g for
30 min, organelle and cytosol fractions being obtained.
3. Results and discussion
3.1. Protein amounts of d1 and d2 isoforms in osteoclasts
We have reported that the V-ATPase a3 isoform increased in
RAW264.7 cells together with induced synthesis of osteoclast marker
proteins upon stimulation with RANKL [6,18]. The d2 isoform is also
induced during osteoclast differentiation [15–17]. Consistent with pre-
vious results, the d2 and a3 isoforms increased to at least more than
100-fold and about 4-fold during differentiation, respectively (Fig. 1A).
The amount of d2 was slightly higher than the detection limit before
stimulation, although it was difﬁcult to quantify. The pattern of d2
induction by RANKL was similar to that of osteoclast speciﬁc enzymes,
TRAP and cathepsin K. On the other hand, ubiquitous d1was detectable
before stimulation and did not increase during differentiation up to
4 days.The amounts of d1 and d2were estimated based on the signal inten-
sities on Western blotting using puriﬁed d1 and d2 as standards
(Fig. 1B). Titrations of signal intensities of standard d isoforms revealed
that anti-d2 antibodies were about 10-fold less sensitive than those
of anti-d1 antibodies (data not shown). Osteoclasts derived from
RAW264.7 cells (4 days after stimulation) contained 2.1±0.6 ng d2 iso-
form per 10 μg cell lysate (Fig. 1C, gray bar), which is about 4 times
higher than the level of d1 (0.5 ± 0.05 ng/10 μg of lysate) (Fig. 1C,
open bars). These results suggest that V-ATPase with d2 comprises
about 80 ± 23% of total enzyme, assuming that all d2 are assembled.
As expected, d1 and d2 were not detectable in the cytosol fraction,
being only found in the organelle fraction (Fig. 1D). This ﬁnding sug-
gests that most of d1 or d2 is assembled in V-ATPase localized in the
membranes. It is noteworthy that both proteins expressed in E. coli
were recovered in a soluble fraction (data not shown), suggesting that
they are soluble proteins when not assembled in V-ATPase.
3.2. Assembly of d2 and a3 in osteoclast V-ATPase
To conﬁrm the association of d2 and a3 in osteoclasts, V-ATPase was
precipitatedwith antibodies. The total cell lysate derived fromosteoclasts
or undifferentiated cells were subjected to immuno-precipitation using
anti-a3 antibodies, and the presence of d1 and d2 was examined in the
precipitate. As expected, d2was detected after differentiation but not be-
fore stimulation (Fig. 2, compare lanes 2 and 3). On the other hand, d1
was immuno-precipitated with anti-a3 antibodies, regardless whether
differentiation had occurred or not (Fig. 2, lanes 2 and 3). These results
clearly indicate that d1 and d2 are assembled, respectively, in V-ATPase
together with a3.
Consistent results were obtained using anti-B2 antibodies (Fig. 2,
lanes 5 and 6), indicating that both a3 and d2 are associated with B2.
These results indicate that V1 and V0 sectors are assembled together in
osteoclasts, since B2 is a component of the V1 sector, and a3 and d2
ones of the V0 sector.
3.3. Expression of V-ATPase with a3 and d2 in osteoclasts derived from
spleen macrophages
For conﬁrmation,we followed osteoclast differentiation frommouse
spleen macrophages upon addition of RANKL, and examined the
presence of V-ATPase with a3 and d2. Basically the same results
as for RAW264.7 cells were obtained: TRAP-positive multinuclear
cells forming calcium phosphate resorption pits were observed
upon stimulation of RANKL (Fig. 3A, upper panels). d2 and a3were in-
duced during differentiation, similar to osteoclast markers (Fig. 3B,
left). The amount of d2, estimated from the signal intensities on
Western blotting using puriﬁed d2 as a standard, comprised about
90% of total d subunit, conﬁrming the result for osteoclasts induced
from RAW264.7 cells. V-ATPase with the a3 isoform was detected at
the osteoclast periphery immunochemically using anti-a3 antibodies,
similar to those differentiated from RAW264.7 ones (data not shown)
[6].
V-ATPase from wild-type osteoclasts was found to contain d1
or d2 when precipitated with anti-a3 antibodies (Fig. 4A, lane 3),
indicating that ubiquitous and osteoclast-speciﬁc V-ATPases having
a3/d1 and a3/d2 isoforms, respectively, are both present in osteo-
clasts. These isoforms were also detectable on precipitation with
anti-B2 antibodies (Fig. 4A, lane 6), conﬁrming that V0 and V1 are as-
sociated in the V-ATPase studied, since the B subunit is a component of
the V1 sector.
3.4. V-ATPase in osteoclasts formed from a3-knock-out mice macrophages
It became of interestwhether or not osteoclasts can be formedwhen
V-ATPasewith a3 is not expressed in the progenitors. a3may affect cell–
cell fusion, since it is a trans-membrane protein. Furthermore, it was
Fig. 3. Induction of d2 in osteoclasts differentiated from wild-type and a3-deﬁcient mice macrophages. (A) Formation of osteoclasts from mouse spleen macrophages. Macrophages
obtained from the spleens of wild-type (WT) or a3 gene-deﬁcient mice (a3 KO) were stimulated with RANKL for 4 days, ﬁxed, and then subjected to TRAP-staining, or nuclei (blue)
and actin (green) staining. For the pit formation assays, cells were cultured on calcium phosphate-coated dishes and allowed to differentiate into osteoclasts. Four days after stimulation,
the formedpits were observed under amicroscope. Cells shown in (A) are not identical. Scale bar, 50 μm. (B) Time courses of expression of a3, d1, d2, and osteoclastmarkers.Macrophages
obtained from the spleens of wild-type (WT) or a3 gene-deﬁcient mice (a3 KO) were allowed to differentiate into osteoclasts as in (A). After gel electrophoresis of cell lysates, V-ATPase
isoforms and osteoclast marker proteins were detected by Western blotting with the corresponding antibodies. β-actin was used as a positive control.
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address these issues, we studied osteoclast differentiation from macro-
phages lacking the a3 gene.
Spleenmacrophages from a3-knock-out mice formed TRAP-positive
multinuclear cells on stimulation (Fig. 3A, lower panels), and osteoclast
marker enzymes were induced following essentially the same time
courses as in wild-type macrophages (Fig. 3B, right). The number of
osteoclasts formed from a3-knock-out macrophages was similar to
that from wild-type ones. However, those from the knockout mice did
not formcalciumphosphate resorption pits (Fig. 3A, right). These results
suggest that the a3 isoform is not required for osteoclast differentiation
itself, but plays a role in bone resorption, consistent with previous
ﬁndings [12].
As shown in Fig. 3B, right, d2 was induced and expressed in a3
knock-out cells following essentially the same time course as in wild
type cells, suggesting that d2 is expressed independently from the
a3 isoform, and possibly assembled in V-ATPase with a1 or a2. It is
noteworthy that the amount of d1 was increased during osteoclast
differentiation from a3-knockout macrophages (Fig. 3B, right). The
increased amount of d1 possibly corresponds to that of a subunit: a2
isoform is induced during differentiation (data not shown).
a1 and a2were detected in the a3-knock-out mice V-ATPase precip-
itated with anti-B2 antibodies (Fig. 4A, lane 8), suggesting that they
could form V-ATPase with d1 or d2. As expected, no a3was detectablein a3-knock-out mice (Fig. 4A, lane 8). These results suggest that the
d2 isoform could form V-ATPase with a1 or a2.
Furthermore, we expressed FLAG-tagged d isoforms in RAW264.7
cells, and immuno-precipitated V-ATPase with these isoforms using
anti-FLAG antibodies. a1, a2, and a3 were co-precipitated with the d1
or d2 isoform (Fig. 4B), indicating that both d1 and d2 can form a
complex with one of these three a subunit isoforms. These results
conﬁrm the presence of V-ATPase with diverse isoform combinations
in osteoclasts.
In this study, we observed that V-ATPase with a3 and d2 was
induced and became a major proton pump for bone resorption in
osteoclasts. However, this V-ATPase may not play roles in cell fusion
leading to multinuclear cells, since a3-deﬁcient macrophages could
form multinuclear osteoclast-like cells. These cells did not show cal-
cium phosphate resorption activity due to the absence of V-ATPase
with a3/d2. Interestingly, V-ATPases with a1/d2 and/or a2/d2 were
expressed in a3-knockout cells. However, they could not function
as V-ATPase with a3/d2.
We suggested previously that late endosomes/lysosomes having a
unique V-ATPase with a3move to the cell periphery and fuse with the
plasma membrane facing bone resorption lacunae [6]. At the same
time, cathepsin K and TRAP are secreted possibly from lysosomes at
the site of bone resorption. As found in this study, d2 was induced
following similar kinetics as those for lysosomal enzymes, and
Fig. 4. Association of the a and d isoforms in osteoclast V-ATPase frommousemacrophages and RAW264.7 cells. (A) Presence of d2 isoforms in V-ATPase in osteoclasts differentiated from
wild-type and a3-deﬁcient mice macrophages. Macrophages from wild type (WT) and a3-deﬁcient (a3KO) mice were treated with (+) or without (−) RANKL, and cell lysates were
prepared from the cells, and subjected to immuno-precipitation using pre-immune serum (lanes 1 and 4), and antibodies against a3 (lanes 2 and 3) or B2 (lanes 5–8). The precipitates
were analyzed using antibodies against the indicated proteins. The amount of a1 was higher in a3 knock-out mice macrophages than in other cells for an unknown reason (lane 7).
(B) Co-precipitation of a isoforms with FLAG-tagged d isoforms. A FLAG-tag was introduced at the C-terminal of the d1 or d2 isoform, and expressed in RAW264.7 cells. Lysates of
these cells were subjected to precipitation with anti-FLAG antibodies, and blotting was performed as in (A).
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with a3/d2 is localized in the membrane of secretory lysosomes
containing cathepsin K and TRAP, and plays a role in bone resorption.
Similar to ARNO, a regulator at vesicle trafﬁcking, the d2 isoform is
indicated to interact with the amino terminus of a3 [17,22,23], suggest-
ing their roles in organelle trafﬁcking. Moreover, d2 is involved in
membrane fusion between osteoclast progenitors [16,17]. Taken
together, V-ATPase with a3 and d2 localized in secretory lysosomes
may be advantageous for trafﬁcking and membrane fusion with the
osteoclast plasma membrane.
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